Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1162 of 1,261
  1. US 6682758

    Water-insoluble drug delivery system

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  2. US 6682741

    &bgr;2 microglobulin fusion proteins and high affinity variants

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  3. US 6682728

    Efficient and selective adenoviral-mediated gene transfer into vascular neointima

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jan 27, 2004 Β· Expires Jan 22, 2024

    expired
  4. EP 1381397

    STABILISIERUNG VON RADIOPHARMAZEUTISCHEN ZUSAMMENSETZUNGEN MIT EINEM HYDROPHILEN THIOETHER ODER EINEM HYDROPHILEN 6-HYDROXY-CHROMAN

    DIATIDE INC [US] Β· Granted Jan 21, 2004 Β· Expires Jan 16, 2024

    expired
  5. US 6680374

    Invaplex from gram negative bacteria, method of purification and methods of use

    The United States of America as represented by the Secretary of the Army Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  6. US 6680060

    Hepatitus A virus vaccines

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  7. US 6680291

    Modified ciliary neurotrophic factor, method of making and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  8. US 6680331

    Lactam and thiolactam derivatives as anesthetic and conscious sedation agents

    The Board of Regents of the University of Texas System Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  9. US 6680299

    4'-substituted leucomycins

    Enanta Pharmaceuticals, Inc. Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  10. US 6680312

    Sulfonamide derivatives, their production and use

    Takeda Chemical Industries Ltd. Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  11. US 6680310

    Methods for preventing antipsychotic-induced weight gain

    Corcept Therapeutics Incorporated Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  12. US 6680176

    Identification of candidate ligands which modulate antigen presenting cells

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  13. US 6680171

    I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  14. US 6680172

    Treatments and markers for cancers of the central nervous system

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  15. US 6680189

    Protein and DNA thereof

    Takeda Chemical Industries Ltd. Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  16. US 6680211

    Fluorescent nanocrystal-embedded microspheres for fluorescence analysis

    BioCrystal, Ltd. Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  17. US 6680196

    Gene that is amplified and overexpressed in cancer and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Jan 20, 2004 Β· Expires Jan 15, 2024

    expired
  18. US 6677363

    Agent for improving ketosis

    Takeda Chemical Industries Ltd. Β· Granted Jan 13, 2004 Β· Expires Jan 8, 2024

    expired
  19. US 6676973

    Method of treating ovarian cancers with cadmium

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jan 13, 2004 Β· Expires Jan 8, 2024

    expired
  20. US 6677359

    N-substituted glycine derivatives

    Vertex Pharmaceuticals Incorporated Β· Granted Jan 13, 2004 Β· Expires Jan 8, 2024

    expired
  21. US 6677340

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. Β· Granted Jan 13, 2004 Β· Expires Jan 8, 2024

    expired
  22. US 6676943

    Human complement C3-degrading protein from Streptococcus pneumoniae

    Regents of the University of Minnesota Β· Granted Jan 13, 2004 Β· Expires Jan 8, 2024

    expired
  23. US 6677306

    Chondrogenic and osteogenic inducing molecule

    Northwestern University Β· Granted Jan 13, 2004 Β· Expires Jan 8, 2024

    expired
  24. US 6676941

    Antibody conjugate formulations for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System Β· Granted Jan 13, 2004 Β· Expires Jan 8, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.